The Patent Finder

Nanopharmaceuticals LLC

Also on record
Records under this name other than the patents Nanopharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Back to Nanopharmaceuticals LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,859,539Compositions of Dual Thyrointegrin Antagonists and Use in Vascular-Associated Disorders
Lapsed on the fee record
Ended Oct 14, 2026 · High confidence
Lapsed on the fee recordEnded Oct 14, 2026High confidence
US 10,060,934Methods for Screening Patients for Resistance to Angioinhibition, Treatment and Prophylaxis Thereof
Lapsed on the fee record
Ended Aug 28, 2026 · High confidence
Lapsed on the fee recordEnded Aug 28, 2026High confidence
US 8,802,240Uses of Formulations of Thyroid Hormone Analogs and Nanoparticulate Forms Thereof to Increase Chemosensivity and Radiosensitivity in Tumor or Cancer Cells
Lapsed on the fee record
Ended Aug 12, 2026 · High confidence
Lapsed on the fee recordEnded Aug 12, 2026High confidence
US 8,668,926Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
Lapsed on the fee record
Ended Mar 11, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 11, 2026USPTO record
US 9,839,614Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
Lapsed on the fee record
Ended Dec 12, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 12, 2025USPTO record
US 8,518,451Thyroid hormone analogs and methods of use
Lapsed on the fee record
Ended Aug 27, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 27, 2025USPTO record
US 9,750,709Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
Term ended
Term ended Jul 17, 2025 · USPTO record
Term endedTerm ended Jul 17, 2025USPTO record
US 9,579,300Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
Term ended
Term ended Nov 18, 2024 · USPTO record
Term endedTerm ended Nov 18, 2024USPTO record
US 9,498,536Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
Term ended
Ended no later than Sep 15, 2024 · USPTO record
Term endedEnded no later than Sep 15, 2024USPTO record
US 10,130,686Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
Term ended
Ended no later than Sep 15, 2024 · USPTO record
Term endedEnded no later than Sep 15, 2024USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited